ECCMID 25th (2015)

Drupal spam blocked by CleanTalk.
Title Content type
Successful treatment of contaminated epidural steroid associated fungal meningitis with Isavuconazole (click for details)
An open-label phase 3 study of Isavuconazole (VITAL): focus on patients with mixed fungal infections (click for details)
Drug interaction profiles of Isavuconazole, voriconazole and posaconazole with immunosuppressants metabolized by CYP4503A4 (CYP3A4) – (click for details)
A comparison of the safety profiles of Isavuconazole vs voriconazole in the phase 3 SECURE study in patients with invasive mould infections – (click for details)
Safety and outcomes in invasive aspergillosis patients with renal vs. no renal impairment treated with Isavuconazole: experience from the SECURE (randomized) and VITAL trials (click for details)
Safety and outcomes in obese patients with invasive fungal disease treated with Isavuconazole in the phase 3 randomised double-blind SECURE trial – (click for details)
Outcome of invasive aspergillosis after allogeneic haematopoietic stemcell transplantation in patientswith invasive aspergillosis before transplantation (click for details)
Evaluation of the RenDx(R) Fungiplex surface-enhanced Raman scattering PCR assay for the detection of Aspergillus in sputum (click for details)
Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infections (click for details)
Performance of serum and bronchoalveolar lavage 1,3 beta-glucan enzyme assays in the diagnosis of invasive aspergillosis in immunocompromised hosts (click for details)


Subscribe to ECCMID 25th (2015)